nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0412	0.0706	CbGbCtD
Bromocriptine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0388	0.0664	CbGbCtD
Bromocriptine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0388	0.0664	CbGbCtD
Bromocriptine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0351	0.06	CbGbCtD
Bromocriptine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0339	0.0581	CbGbCtD
Bromocriptine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0307	0.0525	CbGbCtD
Bromocriptine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0294	0.0503	CbGbCtD
Bromocriptine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0266	0.0455	CbGbCtD
Bromocriptine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0265	0.0453	CbGbCtD
Bromocriptine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0257	0.044	CbGbCtD
Bromocriptine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0232	0.0398	CbGbCtD
Bromocriptine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0232	0.0398	CbGbCtD
Bromocriptine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0223	0.0382	CbGbCtD
Bromocriptine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0216	0.037	CbGbCtD
Bromocriptine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0203	0.0348	CbGbCtD
Bromocriptine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0203	0.0348	CbGbCtD
Bromocriptine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0184	0.0315	CbGbCtD
Bromocriptine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0184	0.0315	CbGbCtD
Bromocriptine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0172	0.0295	CbGbCtD
Bromocriptine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0159	0.0272	CbGbCtD
Bromocriptine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0154	0.0264	CbGbCtD
Bromocriptine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0139	0.0238	CbGbCtD
Bromocriptine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0139	0.0238	CbGbCtD
Bromocriptine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0134	0.0229	CbGbCtD
Bromocriptine—DRD1—nerve—acquired immunodeficiency syndrome	0.00328	0.0442	CbGeAlD
Bromocriptine—HTR7—nerve—acquired immunodeficiency syndrome	0.00205	0.0276	CbGeAlD
Bromocriptine—DRD2—nerve—acquired immunodeficiency syndrome	0.00194	0.0261	CbGeAlD
Bromocriptine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00175	0.0235	CbGeAlD
Bromocriptine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00162	0.0218	CbGeAlD
Bromocriptine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00155	0.0209	CbGeAlD
Bromocriptine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00128	0.0172	CbGeAlD
Bromocriptine—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00126	0.017	CbGeAlD
Bromocriptine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00124	0.0166	CbGeAlD
Bromocriptine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00114	0.0153	CbGeAlD
Bromocriptine—DRD4—brain—acquired immunodeficiency syndrome	0.00112	0.0151	CbGeAlD
Bromocriptine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00109	0.0147	CbGeAlD
Bromocriptine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00103	0.0139	CbGeAlD
Bromocriptine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000993	0.0134	CbGeAlD
Bromocriptine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000992	0.0134	CbGeAlD
Bromocriptine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000967	0.013	CbGeAlD
Bromocriptine—DRD5—nervous system—acquired immunodeficiency syndrome	0.000966	0.013	CbGeAlD
Bromocriptine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000956	0.0129	CbGeAlD
Bromocriptine—DRD5—central nervous system—acquired immunodeficiency syndrome	0.00093	0.0125	CbGeAlD
Bromocriptine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000896	0.012	CbGeAlD
Bromocriptine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000871	0.0117	CbGeAlD
Bromocriptine—DRD2—retina—acquired immunodeficiency syndrome	0.000803	0.0108	CbGeAlD
Bromocriptine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000792	0.0107	CbGeAlD
Bromocriptine—DRD3—brain—acquired immunodeficiency syndrome	0.000788	0.0106	CbGeAlD
Bromocriptine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000775	0.0104	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000763	0.0103	CbGeAlD
Bromocriptine—HTR6—brain—acquired immunodeficiency syndrome	0.000759	0.0102	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000746	0.01	CbGeAlD
Bromocriptine—DRD5—brain—acquired immunodeficiency syndrome	0.000739	0.00993	CbGeAlD
Bromocriptine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000738	0.00993	CbGeAlD
Bromocriptine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000711	0.00956	CbGeAlD
Bromocriptine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00071	0.00955	CbGeAlD
Bromocriptine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000697	0.00937	CbGeAlD
Bromocriptine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000681	0.00916	CbGeAlD
Bromocriptine—HTR2B—blood—acquired immunodeficiency syndrome	0.000664	0.00893	CbGeAlD
Bromocriptine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000634	0.00853	CbGeAlD
Bromocriptine—HTR2B—vagina—acquired immunodeficiency syndrome	0.000615	0.00828	CbGeAlD
Bromocriptine—ADRB1—lung—acquired immunodeficiency syndrome	0.000608	0.00818	CbGeAlD
Bromocriptine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000605	0.00814	CbGeAlD
Bromocriptine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000598	0.00805	CbGeAlD
Bromocriptine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000597	0.00802	CbGeAlD
Bromocriptine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000592	0.00797	CbGeAlD
Bromocriptine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000583	0.00784	CbGeAlD
Bromocriptine—HTR2B—lung—acquired immunodeficiency syndrome	0.000582	0.00783	CbGeAlD
Bromocriptine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000579	0.00779	CbGeAlD
Bromocriptine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000576	0.00775	CbGeAlD
Bromocriptine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000574	0.00771	CbGeAlD
Bromocriptine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000573	0.00771	CbGeAlD
Bromocriptine—HTR7—blood—acquired immunodeficiency syndrome	0.000568	0.00764	CbGeAlD
Bromocriptine—DRD1—brain—acquired immunodeficiency syndrome	0.000564	0.00759	CbGeAlD
Bromocriptine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000563	0.00757	CbGeAlD
Bromocriptine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000558	0.0075	CbGeAlD
Bromocriptine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000552	0.00743	CbGeAlD
Bromocriptine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000548	0.00737	CbGeAlD
Bromocriptine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000548	0.00737	CbGeAlD
Bromocriptine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000542	0.00729	CbGeAlD
Bromocriptine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000539	0.00725	CbGeAlD
Bromocriptine—HTR2A—retina—acquired immunodeficiency syndrome	0.00053	0.00713	CbGeAlD
Bromocriptine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000522	0.00703	CbGeAlD
Bromocriptine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000519	0.00698	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000503	0.00677	CbGeAlD
Bromocriptine—HTR7—lung—acquired immunodeficiency syndrome	0.000498	0.0067	CbGeAlD
Bromocriptine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000484	0.00651	CbGeAlD
Bromocriptine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000483	0.00649	CbGeAlD
Bromocriptine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000476	0.0064	CbGeAlD
Bromocriptine—DRD2—lung—acquired immunodeficiency syndrome	0.000471	0.00634	CbGeAlD
Bromocriptine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000465	0.00625	CbGeAlD
Bromocriptine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000461	0.00621	CbGeAlD
Bromocriptine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000458	0.00616	CbGeAlD
Bromocriptine—HTR1B—brain—acquired immunodeficiency syndrome	0.000457	0.00615	CbGeAlD
Bromocriptine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000453	0.0061	CbGeAlD
Bromocriptine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000445	0.00599	CbGeAlD
Bromocriptine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000444	0.00597	CbGeAlD
Bromocriptine—HTR1D—brain—acquired immunodeficiency syndrome	0.000443	0.00595	CbGeAlD
Bromocriptine—HTR2C—brain—acquired immunodeficiency syndrome	0.000438	0.0059	CbGeAlD
Bromocriptine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000436	0.00587	CbGeAlD
Bromocriptine—ADRB1—brain—acquired immunodeficiency syndrome	0.00043	0.00579	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000428	0.00576	CbGeAlD
Bromocriptine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000424	0.0057	CbGeAlD
Bromocriptine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00042	0.00565	CbGeAlD
Bromocriptine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000417	0.00561	CbGeAlD
Bromocriptine—HTR2B—brain—acquired immunodeficiency syndrome	0.000412	0.00554	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000408	0.00549	CbGeAlD
Bromocriptine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000402	0.0054	CbGeAlD
Bromocriptine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000398	0.00535	CbGeAlD
Bromocriptine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000397	0.00535	CbGeAlD
Bromocriptine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000386	0.0052	CbGeAlD
Bromocriptine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000372	0.005	CbGeAlD
Bromocriptine—HTR1A—brain—acquired immunodeficiency syndrome	0.000369	0.00496	CbGeAlD
Bromocriptine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000365	0.00492	CbGeAlD
Bromocriptine—HTR2A—blood—acquired immunodeficiency syndrome	0.000354	0.00477	CbGeAlD
Bromocriptine—HTR7—brain—acquired immunodeficiency syndrome	0.000353	0.00474	CbGeAlD
Bromocriptine—ABCB1—retina—acquired immunodeficiency syndrome	0.000347	0.00467	CbGeAlD
Bromocriptine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000344	0.00463	CbGeAlD
Bromocriptine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000341	0.00459	CbGeAlD
Bromocriptine—ADRA1A—brain—acquired immunodeficiency syndrome	0.00034	0.00458	CbGeAlD
Bromocriptine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000338	0.00455	CbGeAlD
Bromocriptine—DRD2—brain—acquired immunodeficiency syndrome	0.000333	0.00448	CbGeAlD
Bromocriptine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000329	0.00442	CbGeAlD
Bromocriptine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000328	0.00441	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000326	0.00438	CbGeAlD
Bromocriptine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000324	0.00436	CbGeAlD
Bromocriptine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000313	0.00421	CbGeAlD
Bromocriptine—HTR2A—lung—acquired immunodeficiency syndrome	0.000311	0.00418	CbGeAlD
Bromocriptine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000288	0.00387	CbGeAlD
Bromocriptine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Bromocriptine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Bromocriptine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Bromocriptine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00112	CcSEcCtD
Bromocriptine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00112	CcSEcCtD
Bromocriptine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00112	CcSEcCtD
Bromocriptine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00112	CcSEcCtD
Bromocriptine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00112	CcSEcCtD
Bromocriptine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bromocriptine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bromocriptine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bromocriptine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bromocriptine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00111	CcSEcCtD
Bromocriptine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Bromocriptine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000277	0.00373	CbGeAlD
Bromocriptine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bromocriptine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bromocriptine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bromocriptine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bromocriptine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bromocriptine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.0011	CcSEcCtD
Bromocriptine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00109	CcSEcCtD
Bromocriptine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Bromocriptine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Bromocriptine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Bromocriptine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Bromocriptine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000271	0.00109	CcSEcCtD
Bromocriptine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00108	CcSEcCtD
Bromocriptine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.00108	CcSEcCtD
Bromocriptine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Bromocriptine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Bromocriptine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Bromocriptine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Bromocriptine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Bromocriptine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Bromocriptine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Bromocriptine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Bromocriptine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Bromocriptine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Bromocriptine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Bromocriptine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000266	0.00107	CcSEcCtD
Bromocriptine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000266	0.00358	CbGeAlD
Bromocriptine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000266	0.00106	CcSEcCtD
Bromocriptine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Bromocriptine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Bromocriptine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Bromocriptine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Bromocriptine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Bromocriptine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Bromocriptine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Bromocriptine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Bromocriptine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Bromocriptine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Bromocriptine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Bromocriptine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000259	0.00348	CbGeAlD
Bromocriptine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Bromocriptine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Bromocriptine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Bromocriptine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Bromocriptine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Bromocriptine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Bromocriptine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Bromocriptine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Bromocriptine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000256	0.00345	CbGeAlD
Bromocriptine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00103	CcSEcCtD
Bromocriptine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00103	CcSEcCtD
Bromocriptine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00102	CcSEcCtD
Bromocriptine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Bromocriptine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00102	CcSEcCtD
Bromocriptine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00102	CcSEcCtD
Bromocriptine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Bromocriptine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Bromocriptine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Bromocriptine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00025	0.001	CcSEcCtD
Bromocriptine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.001	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00025	0.00336	CbGeAlD
Bromocriptine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.000999	CcSEcCtD
Bromocriptine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.000998	CcSEcCtD
Bromocriptine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.000998	CcSEcCtD
Bromocriptine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000997	CcSEcCtD
Bromocriptine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000249	0.000995	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000995	CcSEcCtD
Bromocriptine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000994	CcSEcCtD
Bromocriptine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.000992	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.000992	CcSEcCtD
Bromocriptine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000991	CcSEcCtD
Bromocriptine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000248	0.000991	CcSEcCtD
Bromocriptine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.000991	CcSEcCtD
Bromocriptine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.000988	CcSEcCtD
Bromocriptine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000247	0.00332	CbGeAlD
Bromocriptine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000987	CcSEcCtD
Bromocriptine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000987	CcSEcCtD
Bromocriptine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.000983	CcSEcCtD
Bromocriptine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000246	0.000983	CcSEcCtD
Bromocriptine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000245	0.000982	CcSEcCtD
Bromocriptine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00098	CcSEcCtD
Bromocriptine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000245	0.00098	CcSEcCtD
Bromocriptine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000979	CcSEcCtD
Bromocriptine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000977	CcSEcCtD
Bromocriptine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.000976	CcSEcCtD
Bromocriptine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000244	0.00328	CbGeAlD
Bromocriptine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000972	CcSEcCtD
Bromocriptine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000971	CcSEcCtD
Bromocriptine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000969	CcSEcCtD
Bromocriptine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000968	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000967	CcSEcCtD
Bromocriptine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000241	0.000966	CcSEcCtD
Bromocriptine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000963	CcSEcCtD
Bromocriptine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000961	CcSEcCtD
Bromocriptine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000961	CcSEcCtD
Bromocriptine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00096	CcSEcCtD
Bromocriptine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00024	0.00096	CcSEcCtD
Bromocriptine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000239	0.000957	CcSEcCtD
Bromocriptine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000956	CcSEcCtD
Bromocriptine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000952	CcSEcCtD
Bromocriptine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000238	0.000952	CcSEcCtD
Bromocriptine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000238	0.000951	CcSEcCtD
Bromocriptine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.000951	CcSEcCtD
Bromocriptine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.00095	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.000949	CcSEcCtD
Bromocriptine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000237	0.000949	CcSEcCtD
Bromocriptine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.000948	CcSEcCtD
Bromocriptine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000237	0.000948	CcSEcCtD
Bromocriptine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000947	CcSEcCtD
Bromocriptine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.000946	CcSEcCtD
Bromocriptine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000236	0.000943	CcSEcCtD
Bromocriptine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000236	0.000942	CcSEcCtD
Bromocriptine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.000941	CcSEcCtD
Bromocriptine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00094	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00094	CcSEcCtD
Bromocriptine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.000938	CcSEcCtD
Bromocriptine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000234	0.000935	CcSEcCtD
Bromocriptine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000233	0.000934	CcSEcCtD
Bromocriptine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000934	CcSEcCtD
Bromocriptine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000933	CcSEcCtD
Bromocriptine—ABCB1—blood—acquired immunodeficiency syndrome	0.000232	0.00312	CbGeAlD
Bromocriptine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000232	0.000929	CcSEcCtD
Bromocriptine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000927	CcSEcCtD
Bromocriptine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000231	0.000926	CcSEcCtD
Bromocriptine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00092	CcSEcCtD
Bromocriptine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000918	CcSEcCtD
Bromocriptine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000916	CcSEcCtD
Bromocriptine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000914	CcSEcCtD
Bromocriptine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000913	CcSEcCtD
Bromocriptine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.000913	CcSEcCtD
Bromocriptine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000908	CcSEcCtD
Bromocriptine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000908	CcSEcCtD
Bromocriptine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000907	CcSEcCtD
Bromocriptine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.000906	CcSEcCtD
Bromocriptine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000906	CcSEcCtD
Bromocriptine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000904	CcSEcCtD
Bromocriptine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000225	0.00302	CbGeAlD
Bromocriptine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000899	CcSEcCtD
Bromocriptine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.000896	CcSEcCtD
Bromocriptine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000224	0.00301	CbGeAlD
Bromocriptine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000895	CcSEcCtD
Bromocriptine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.000895	CcSEcCtD
Bromocriptine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000223	0.000894	CcSEcCtD
Bromocriptine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00089	CcSEcCtD
Bromocriptine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000885	CcSEcCtD
Bromocriptine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000884	CcSEcCtD
Bromocriptine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00022	0.00088	CcSEcCtD
Bromocriptine—HTR2A—brain—acquired immunodeficiency syndrome	0.00022	0.00296	CbGeAlD
Bromocriptine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000879	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000878	CcSEcCtD
Bromocriptine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000877	CcSEcCtD
Bromocriptine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000873	CcSEcCtD
Bromocriptine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000873	CcSEcCtD
Bromocriptine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000872	CcSEcCtD
Bromocriptine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000872	CcSEcCtD
Bromocriptine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00087	CcSEcCtD
Bromocriptine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000869	CcSEcCtD
Bromocriptine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000869	CcSEcCtD
Bromocriptine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000869	CcSEcCtD
Bromocriptine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.000865	CcSEcCtD
Bromocriptine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000861	CcSEcCtD
Bromocriptine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000215	0.0029	CbGeAlD
Bromocriptine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000851	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000845	CcSEcCtD
Bromocriptine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000844	CcSEcCtD
Bromocriptine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000844	CcSEcCtD
Bromocriptine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000838	CcSEcCtD
Bromocriptine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000838	CcSEcCtD
Bromocriptine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000837	CcSEcCtD
Bromocriptine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000832	CcSEcCtD
Bromocriptine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000832	CcSEcCtD
Bromocriptine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.000832	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000831	CcSEcCtD
Bromocriptine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00083	CcSEcCtD
Bromocriptine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000825	CcSEcCtD
Bromocriptine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000824	CcSEcCtD
Bromocriptine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000824	CcSEcCtD
Bromocriptine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000822	CcSEcCtD
Bromocriptine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000819	CcSEcCtD
Bromocriptine—ABCB1—lung—acquired immunodeficiency syndrome	0.000204	0.00274	CbGeAlD
Bromocriptine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000812	CcSEcCtD
Bromocriptine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000808	CcSEcCtD
Bromocriptine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000806	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000806	CcSEcCtD
Bromocriptine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000805	CcSEcCtD
Bromocriptine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000804	CcSEcCtD
Bromocriptine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000804	CcSEcCtD
Bromocriptine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000804	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.0008	CcSEcCtD
Bromocriptine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000798	CcSEcCtD
Bromocriptine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000789	CcSEcCtD
Bromocriptine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000786	CcSEcCtD
Bromocriptine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000777	CcSEcCtD
Bromocriptine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.000777	CcSEcCtD
Bromocriptine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000774	CcSEcCtD
Bromocriptine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000774	CcSEcCtD
Bromocriptine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000773	CcSEcCtD
Bromocriptine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000769	CcSEcCtD
Bromocriptine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000767	CcSEcCtD
Bromocriptine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000766	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000763	CcSEcCtD
Bromocriptine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000762	CcSEcCtD
Bromocriptine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.00076	CcSEcCtD
Bromocriptine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000189	0.00254	CbGeAlD
Bromocriptine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000752	CcSEcCtD
Bromocriptine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000742	CcSEcCtD
Bromocriptine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000738	CcSEcCtD
Bromocriptine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000738	CcSEcCtD
Bromocriptine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000731	CcSEcCtD
Bromocriptine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000729	CcSEcCtD
Bromocriptine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000727	CcSEcCtD
Bromocriptine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000182	0.00244	CbGeAlD
Bromocriptine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000725	CcSEcCtD
Bromocriptine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000724	CcSEcCtD
Bromocriptine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000722	CcSEcCtD
Bromocriptine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00072	CcSEcCtD
Bromocriptine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000702	CcSEcCtD
Bromocriptine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000699	CcSEcCtD
Bromocriptine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000696	CcSEcCtD
Bromocriptine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000693	CcSEcCtD
Bromocriptine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000693	CcSEcCtD
Bromocriptine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000689	CcSEcCtD
Bromocriptine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000683	CcSEcCtD
Bromocriptine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000672	CcSEcCtD
Bromocriptine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00067	CcSEcCtD
Bromocriptine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.00067	CcSEcCtD
Bromocriptine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000653	CcSEcCtD
Bromocriptine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000647	CcSEcCtD
Bromocriptine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000646	CcSEcCtD
Bromocriptine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000641	CcSEcCtD
Bromocriptine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.00064	CcSEcCtD
Bromocriptine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000639	CcSEcCtD
Bromocriptine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000637	CcSEcCtD
Bromocriptine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000622	CcSEcCtD
Bromocriptine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000617	CcSEcCtD
Bromocriptine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000617	CcSEcCtD
Bromocriptine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000616	CcSEcCtD
Bromocriptine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000613	CcSEcCtD
Bromocriptine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000604	CcSEcCtD
Bromocriptine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000594	CcSEcCtD
Bromocriptine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000589	CcSEcCtD
Bromocriptine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000588	CcSEcCtD
Bromocriptine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000585	CcSEcCtD
Bromocriptine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000581	CcSEcCtD
Bromocriptine—ABCB1—brain—acquired immunodeficiency syndrome	0.000144	0.00194	CbGeAlD
Bromocriptine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000139	0.00187	CbGeAlD
Bromocriptine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000555	CcSEcCtD
Bromocriptine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.61e-05	0.000285	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.6e-05	0.000284	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.6e-05	0.000284	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.6e-05	0.000283	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.6e-05	0.000283	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.59e-05	0.000282	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.58e-05	0.000282	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.58e-05	0.000281	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.57e-05	0.000281	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.00028	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.56e-05	0.000279	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.000279	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.52e-05	0.000275	CbGpPWpGaD
Bromocriptine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000274	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.51e-05	0.000274	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.5e-05	0.000273	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.5e-05	0.000272	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.48e-05	0.000271	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.48e-05	0.000271	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.00027	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.46e-05	0.000269	CbGpPWpGaD
Bromocriptine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.46e-05	0.000268	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.45e-05	0.000267	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.45e-05	0.000267	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.45e-05	0.000267	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.45e-05	0.000267	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.43e-05	0.000265	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.41e-05	0.000263	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.000263	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.41e-05	0.000263	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.39e-05	0.000261	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.39e-05	0.000261	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.39e-05	0.000261	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.39e-05	0.000261	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.38e-05	0.000259	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.38e-05	0.000259	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000259	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.37e-05	0.000259	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.36e-05	0.000257	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.000257	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.35e-05	0.000256	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.34e-05	0.000255	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.34e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.32e-05	0.000253	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.31e-05	0.000251	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.00025	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.27e-05	0.000247	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.26e-05	0.000246	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.23e-05	0.000243	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.23e-05	0.000243	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.21e-05	0.000241	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.21e-05	0.000241	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.2e-05	0.00024	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.2e-05	0.000239	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.000239	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.000239	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.18e-05	0.000237	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000237	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.17e-05	0.000236	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.16e-05	0.000236	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.16e-05	0.000236	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.16e-05	0.000235	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.16e-05	0.000235	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.15e-05	0.000235	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.000234	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.000234	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.000233	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.13e-05	0.000233	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000233	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.13e-05	0.000232	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.13e-05	0.000232	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.13e-05	0.000232	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.12e-05	0.000232	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.12e-05	0.000231	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.12e-05	0.000231	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.12e-05	0.000231	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.11e-05	0.00023	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.000229	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.1e-05	0.000229	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.09e-05	0.000228	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.07e-05	0.000225	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.06e-05	0.000225	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.06e-05	0.000225	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.06e-05	0.000225	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.03e-05	0.000222	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.03e-05	0.000222	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.03e-05	0.000222	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.03e-05	0.000222	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2e-05	0.000218	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.000217	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.000215	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.000215	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.97e-05	0.000215	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.97e-05	0.000215	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000214	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.96e-05	0.000214	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000214	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.000212	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000212	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000211	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.93e-05	0.00021	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.92e-05	0.000209	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.000209	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000209	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.89e-05	0.000206	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.89e-05	0.000206	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.88e-05	0.000205	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.000204	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.000204	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.86e-05	0.000203	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.86e-05	0.000203	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.86e-05	0.000203	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.85e-05	0.000201	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.84e-05	0.000201	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.84e-05	0.000201	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.0002	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.0002	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.83e-05	0.0002	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000197	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.8e-05	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.8e-05	0.000197	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.000197	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.78e-05	0.000194	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.76e-05	0.000192	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.7e-05	0.000185	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.7e-05	0.000185	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.68e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000183	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.68e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.68e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.67e-05	0.000182	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000181	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000181	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.65e-05	0.00018	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.63e-05	0.000178	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.62e-05	0.000177	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.61e-05	0.000176	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000174	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.59e-05	0.000173	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.57e-05	0.000172	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.57e-05	0.000171	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.57e-05	0.000171	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.55e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.53e-05	0.000167	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000166	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.000166	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000165	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.5e-05	0.000164	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.49e-05	0.000163	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000162	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000161	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.47e-05	0.00016	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000159	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.45e-05	0.000159	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.45e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000156	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.42e-05	0.000155	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000154	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000153	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.4e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000151	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.38e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000149	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000148	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000145	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000139	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.26e-05	0.000138	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000137	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000135	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.21e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.21e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.13e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.13e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000121	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.1e-05	0.00012	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000119	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.09e-05	0.000118	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000114	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000113	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.82e-06	0.000107	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	9.79e-06	0.000107	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.77e-06	0.000107	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.69e-06	0.000106	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.69e-06	0.000106	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.64e-06	0.000105	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.64e-06	0.000105	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.83e-06	9.63e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.79e-06	9.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.75e-06	9.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.71e-06	9.5e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.69e-06	9.48e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.45e-06	9.21e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.4e-06	9.17e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.4e-06	9.17e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.36e-06	9.12e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.17e-06	8.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.13e-06	8.87e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.04e-06	8.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8e-06	8.73e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.42e-06	8.09e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.38e-06	8.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.3e-06	7.96e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.26e-06	7.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.14e-06	7.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.11e-06	7.75e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	6.77e-06	7.38e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.71e-06	7.32e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.7e-06	7.31e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.66e-06	7.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.64e-06	7.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.61e-06	7.2e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.52e-06	7.11e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.41e-06	7e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.12e-06	6.68e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.77e-06	6.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.7e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.7e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.4e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.19e-06	5.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.14e-06	5.61e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.96e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.94e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.8e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.73e-06	5.16e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.36e-06	4.75e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.29e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.2e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.17e-06	4.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.9e-06	4.26e-05	CbGpPWpGaD
